Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001493152-22-016402

Options or other derivatives

  • Director acquired 22,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Papapetropoulos Spyros Director 2022-06-08 Grant or award · Stock Option (Right to Buy) +22,000 $0.92 $20,240 32,000 D
Loading xslF345X03/ownership.xml…